A new treatment for postpartum depression, which affects about one in nine new mothers in the U.S., could be approved by the Food and Drug Administration this week.
The pill, called zuranolone, has shown to improve depression symptoms among new mothers as early as three days after they started it.
Support The Readers Bureau. Buy A T-Shirt Today (4 different colors)! click https://www.bonfire.com/one-love-72/?fbclid=IwAR2bod-XSyrCPutOwG_SMnKiInk6Bqe2kCtjBsAFISqHluQcujrF2UUkFew
Readers Bureau, Contributor
Edited by Jesus Chan
Do you want to add feedback to this story?
Please add a comment in the box below or send an email to firstname.lastname@example.org. Call us at 646-874-7976. SUBSCRIBE CLICK https://www.youtube.com/c/yvadbillingsreadersbureau
Like our Facebook page https://www.facebook.com/TheReadersBureau
Follow us on Twitter https://twitter.com/readersbureau21